Timber Pharmaceuticals Announces Bankruptcy and Cancellation of Shares

Pharmaceutical products for wood (TMBRQ) shared an update.

Trex Wind-down, Inc., formerly known as Timber Pharmaceuticals, has confirmed its Chapter 11 bankruptcy plan, resulting in the cancellation of all of its common stock, with no recovery to shareholders. The effectiveness of the plan will also result in the company’s deregistration of its securities and suspension of its reporting obligations, as it files necessary amendments and forms with the SEC. Although the Company has made forward-looking statements regarding these actions, it cautions that actual results may vary and future developments are uncertain.

Learn more about TMBRQ stock at TipRanks Stock Analysis Page.